Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
Transfusion|September 13, 2024
Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypassMassimo Griselli, Sameh M Said, Philip C Spinella, et al.
Blood|July 31, 2015
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopeniaAnja J Gerrits, Emily A Leven, Andrew L Frelinger, et al.
Transfusion|December 15, 2018
Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methodsSarah K Harm, Mark H Yazer, Carolina B Bub, et al.
Transfusion|September 8, 2016
International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testingClaudia I Chapuy, Maria D Aguad, Rachel T Nicholson, et al.
Elife|June 1, 2021
Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patientsChristian A Di Buduo, Pierre-Alexandre Laurent, Carlo Zaninetti, et al.
Rheumatology (Oxford, England)|May 15, 2018
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonistsZelie Guitton, Louis Terriou, Jean-Christophe Lega, et al.
The New England Journal of Medicine|October 20, 2006
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITPJames B Bussel, David J Kuter, James N George, et al.
American Journal of Hematology|October 27, 2020
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
American Journal of Hematology|November 10, 2020
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatmentNichola Cooper, Alexandra Kruse, Caroline Kruse, et al.
Thrombosis and Haemostasis|December 24, 2024
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP SummitDimpy Modi, Saifur R Chowdhury, Syed Mahamad, et al.
Pageof 27